Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Martinelli

Showing results (21-30 of 657) with videos related to

Pageof 66
Sort By:
Cancers|September 9, 2022
Pegfilgrastim in Supportive Care of Hodgkin LymphomaClaudio Cerchione, Davide Nappi, Alessandra Romano, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapyGiovanni Martinelli, Simona Soverini, Ilaria Iacobucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Hematologic toxicity and double autografting of stem cells after myeloablative activities of yttrium-90-ibritumomab tiuxetanAnna Vanazzi, Marta Cremonesi, Giovanni Paganelli, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
New targets for Ph+ leukaemia therapyGiovanni Martinelli, Ilaria Iacobucci, Cristina Papayannidis, et al.
Seminars in Hematology|February 4, 2003
Interferon-alfa for chronic myeloid leukemiaMichele Baccarani, Domenico Russo, Gianantonio Rosti, et al.
Seminars in Hematology|June 5, 2003
The cytogenetic response as a surrogate marker of survivalGianantonio Rosti, Nicoletta Testoni, Giovanni Martinelli, et al.
Annals of Hematology|October 12, 2011
Secondary haematological malignancies after radioimmunotherapyFederica Gigli, Angelo Gardellini, Paola Bertazzoni, et al.
Panminerva Medica|September 21, 2020
Old and new generation immunomodulatory drugs in multiple myelomaDaniele Derudas, Francesca Capraro, Giovanni Martinelli, et al.
Haematologica|January 29, 2003
FLT3 inhibition as tailored therapy for acute myeloid leukemiaGiovanni Martinelli, Pier Paolo Piccaluga, Francesco Lo Coco
Frontiers in Oncology|February 11, 2021
PET/CT in Multiple Myeloma: Beyond FDGFederica Matteucci, Giovanni Paganelli, Giovanni Martinelli, et al.
Pageof 66

Showing results (21-30 of 657) with videos related to

Sort By:
Pageof 66
Cancers|September 9, 2022
Pegfilgrastim in Supportive Care of Hodgkin LymphomaClaudio Cerchione, Davide Nappi, Alessandra Romano, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapyGiovanni Martinelli, Simona Soverini, Ilaria Iacobucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Hematologic toxicity and double autografting of stem cells after myeloablative activities of yttrium-90-ibritumomab tiuxetanAnna Vanazzi, Marta Cremonesi, Giovanni Paganelli, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
New targets for Ph+ leukaemia therapyGiovanni Martinelli, Ilaria Iacobucci, Cristina Papayannidis, et al.
Seminars in Hematology|February 4, 2003
Interferon-alfa for chronic myeloid leukemiaMichele Baccarani, Domenico Russo, Gianantonio Rosti, et al.
Seminars in Hematology|June 5, 2003
The cytogenetic response as a surrogate marker of survivalGianantonio Rosti, Nicoletta Testoni, Giovanni Martinelli, et al.
Annals of Hematology|October 12, 2011
Secondary haematological malignancies after radioimmunotherapyFederica Gigli, Angelo Gardellini, Paola Bertazzoni, et al.
Panminerva Medica|September 21, 2020
Old and new generation immunomodulatory drugs in multiple myelomaDaniele Derudas, Francesca Capraro, Giovanni Martinelli, et al.
Haematologica|January 29, 2003
FLT3 inhibition as tailored therapy for acute myeloid leukemiaGiovanni Martinelli, Pier Paolo Piccaluga, Francesco Lo Coco
Frontiers in Oncology|February 11, 2021
PET/CT in Multiple Myeloma: Beyond FDGFederica Matteucci, Giovanni Paganelli, Giovanni Martinelli, et al.
Pageof 66